A Review of Intervention Strategies for Areca Nut Use Cessation

Area of Science:

• Public Health
• Addiction Medicine
• Behavioral Science

Background:

• Areca nut (AN) use is widespread globally, particularly in the Asia-Pacific region, leading to dependence and significant adverse health effects.
• The International Agency for Research on Cancer (IARC) classifies areca nut as a Group 1 carcinogen, highlighting its severe health risks.
• Despite documented harms, low harm perception and limited intervention availability hinder efforts to reduce areca nut consumption.

Purpose of the Study:

• To review and analyze the range and efficacy of existing interventional studies focused on areca nut use cessation.
• To identify effective strategies for promoting cessation of areca nut consumption.

Main Methods:

• A narrative review of studies published between 1990 and 2021 was conducted.
• Literature search was performed using major electronic databases: PubMed, Embase, and Scopus.
• Interventions were categorized into educational, psychological, and pharmacological approaches.

Main Results:

• Educational interventions were effective in increasing knowledge about the harms associated with areca nut use.
• Psychological interventions demonstrated potential in enhancing motivation to quit and aiding in the reduction or cessation of areca nut use.
• Pharmacological studies indicated that antidepressants could assist in reducing or ceasing areca nut use among psychiatric patients with comorbid depressive disorders.

Conclusions:

• The current body of research on areca nut cessation interventions is limited, with most studies focusing on short-term outcomes.
• Further investigation into pharmacotherapeutic interventions for areca nut cessation is warranted.
• Development of evidence-based psychosocial interventions and longitudinal research with adequate sample sizes and follow-up durations are crucial for establishing effective cessation strategies.